Loading...

HAVN Life Sciences Inc.

HAVLFPNK
Healthcare
Biotechnology
$0.00
$0.00(0.00%)

HAVN Life Sciences Inc. (HAVLF) Company Profile & Overview

Explore HAVN Life Sciences Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

HAVN Life Sciences Inc. (HAVLF) Company Profile & Overview

HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is headquartered in Richmond, Canada.

SectorHealthcare
IndustryBiotechnology
CEOTim Moore

Contact Information

604-687-7130
22071 Fraserwood Way, Port Moody, BC, V6W 1J5

Company Facts

6 Employees
IPO DateJan 8, 2021
CountryCA
Actively Trading

Frequently Asked Questions

;